Gefitinib

Product Description

Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Gefitinib, with an Oncology indication. Dosage strength: 250mg. Dosage form: film coated tablets. It is a new available dossier. Contact us for more information.

Bluepharma Industria Farmaceutica S.A.

  • PT
  • 2015
    On CPhI since
  • 5
    Certificates
Contract Service
Manufacturer/Innovator
Specifications
  • Selling Points
    International Approvals/Standards; Quality Service
  • Supplied from
    Portugal

Bluepharma Industria Farmaceutica S.A.

  • PT
  • 2015
    On CPhI since
  • 5
    Certificates
Contract Service
Manufacturer/Innovator

More Products from Bluepharma Industria Farmaceutica S.A.

  • Abiraterone

    Product Abiraterone

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Abiraterone, with an Oncology indication. Dosage strength: 500mg. Dosage form: film coated tablets. It is a new available dossier. Contact us for more information.
  • Abiraterone

    Product Abiraterone

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Abiraterone, with an Oncology indication. Dosage strength: 250mg. Dosage form: tablets. It is a new available dossier. Contact us for more information.



  • Alprazolam

    Product Alprazolam

    Bluepharma, S.A. offers a wide range of pharmaceutical product portfolio which includes Alprazolam, with an Anxiety indication. Dosage strength: 0.25mg, 0.5mg, 1mg. Dosage form: tablets. It is a new available dossier. Contact us for more information.
  • Amlodipine

    Product Amlodipine

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Amlodipine, with a Hypertension indication. Dosage strength: 5mg and 100mg. Dosage form: tablets. It is a new available dossier. Contact us for more information.
  • Azithromycin

    Product Azithromycin

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Azithromycin, with an Anti-infective. Dosage strength: 250mg, 500mg and 600mg. Dosage form: film coated tablets. It is a new available dossier. Contact us for more information.
  • Febuxostat

    Product Febuxostat

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Febuxostat, with a Chronic gout indication. Dosage strength: 80mg and 120mg. Dosage form: film coated tablets. It is a new available dossier. Contact us for more information.

  • Fingolimod

    Product Fingolimod

    Bluepharma, S.A. offers a wide range of pharmaceutical product portfolio which includes Fingolimod, with a Multiple Sclerosis indication. Dosage strength: 0.5mg. Dosage form: Capsules. It is an available dossier. Contact us for more information.
  • Palbociclib

    Product Palbociclib

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Palbociclib, with an Oncology indication. Dosage strength: 75mg, 100mg and 125mg. Dosage form: capsules. It is an available dossier. Contact us for more information.
  • Paroxetine

    Product Paroxetine

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Paroxetine, with a Major Depression and Anxiety disorders indication. Dosage strength: 20mg. Dosage form: film coated tablets. It is a new available dossier. Contact us for more information.
  • Rivaroxban

    Product Rivaroxban

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Rivaroxban, with an Anti-thrombotic indication. Dosage strength: 10mg, 15mg and 20mg. Dosage form: film coated tablets. It is a new available dossier. Contact us for more information.
  • Sitagliptin

    Product Sitagliptin

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Sitagliptin, with a Diabetes Mellitus indication. Dosage strength: 25mg, 50mg and 100mg. Dosage form: tablets. It is a new available dossier. Contact us for more information.
  • Sitagliptin + Metformin

    Product Sitagliptin + Metformin

    Bluepharma, S.A. offers a wide range of pharmaceutical tablets which includes Sitagliptin + Metformin, with a Diabetes Mellitus indication. Dosage strength: 50mg+500mg, 50mg+850mg and 50mg+1000mg. Dosage form: tablets. It is an available dossier. Contact us for more information.

Bluepharma Industria Farmaceutica S.A. resources

  • News New Bluepharma plant completed at the end of 2021

    Bluepharma has a strategic plan for its growth, called "Bluepharma Acelera 2030"
  • Video Bluepharma´s Presentation

    Bluepharma is a Portuguese Group with 20 years, more than 700 employees and 20 innovative companies that cover all stages of the pharmaceutical industry value chain of the drug, from R&D to the market, imposing itself for the excellence of its production unit, the quality and training of its employees and the experience and dynamism of its management team.
  • News Bluepharma celebrates 20 years and prepares a investment of €200 million

    Bluepharma Group celebrates 20 years in 2021, the year in which it prepares a strategic growth plan that represents an investment of €200 million for the next 10 years
  • Video “Reflections in Future”, Bluepharma´s 20 years celebration photographic exhibition.

    www.bluepharma20anos.pt

    Bluepharma turns 20 years in 2021! 20 years that have passed like a flash.

    To honor all employees who have been part of these two decades, Bluepharma has prepared a photographic exhibition entitled “Reflections in Future”, with photos by Pedro Medeiros.

    “Reflections in Future” is an exhibition with 20 photographs that celebrates the 20th Anniversary of Bluepharma, the Portuguese pharmaceutical company that was born in Coimbra and that, step by step, went from a unit with 58 workers to a group of 20 companies, with 700 employees, including 260 researchers.

    With all the authenticity achieved by the telephoto lens, centered on People, Investment, Research and Quality, we present you the challenge posed in each procedure.

    This exhibition can also be seen as a dynamic and didactic display of the complexity of the pharmaceutical industry's value chain.

    From Research & Development to kno...
  • News PEGASEMP™, the lead product of TREAT U, received the Orphan Drug Designation for the treatment of malignant mesothelioma

    “PEGASEMP™ allows inhibition of tumor growth and prevents metastization of mesothelioma, with low incidence of side effects.

Recommended products